Mohsen Karimi
- Hematology top 1%
- Acute Myeloid Leukemia Research 19
- Hematopoietic Stem Cell Transplantation 4
- Genetics top 5%
- Hemoglobinopathies and Related Disorders 7
- Chronic Lymphocytic Leukemia Research 4
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 21
- Cancer-related gene regulation 7
- Histone Deacetylase Inhibitors Research 5
- RNA modifications and cancer 5
- Cancer Research top 10%
- Co-authors
- Tomas J. EkströmEva Hellström‐LindbergMartin SchallingCatharina LarssonGeorgy BakalkinSven‐Erik JohanssonMonika JanssonStefan Deneberg
- Cited by
- HematologyGeneticsMolecular Biology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Blood (6 papers)Bioinformatics (1 paper)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Mohsen Karimi
48 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 120
- Hematology 636
- Genetics 259
- Molecular Biology 1.5k
- Cancer Research 278
- Pediatrics, Perinatology and Child Health 305
Countries citing papers authored by Mohsen Karimi
This map shows the geographic impact of Mohsen Karimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohsen Karimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohsen Karimi more than expected).
Fields of papers citing papers by Mohsen Karimi
This network shows the impact of papers produced by Mohsen Karimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohsen Karimi. The network helps show where Mohsen Karimi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohsen Karimi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2019 | 16 | |
| 3 | 2018 | 141 | |
| 4 | 2018 | 2 | |
| 5 | 2018 | 8 | |
| 6 | 2017 | 121 | |
| 7 | 2017 | 49 | |
| 8 | 2016 | 29 | |
| 9 | 2014 | 60 | |
| 10 | 2014 | 104 | |
| 11 | 2014 | 65 | |
| 12 | 2013 | 26 | |
| 13 | 2012 | 74 | |
| 14 | 2011 | 19 | |
| 15 | 2010 | 190 | |
| 16 | 2008 | 47 | |
| 17 | 2008 | 50 | |
| 18 | 2007 | 49 | |
| 19 | 2007 | 304 | |
| 20 | Disturbances in calcium metabolism in childhood lymphoblastic leukemia, before and after chemotherapy | 2003 | 1 |
About Mohsen Karimi
Mohsen Karimi is a scholar working on Drug Discovery, Hematology and Genetics, having authored 49 papers that have together received 2.5k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (21 papers), Acute Myeloid Leukemia Research (19 papers), Cancer-related gene regulation (7 papers), Hemoglobinopathies and Related Disorders (7 papers), Histone Deacetylase Inhibitors Research (5 papers), RNA modifications and cancer (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). The work is most often cited by research in Hematology (636 citations), Genetics (259 citations) and Molecular Biology (1.5k citations). Mohsen Karimi has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Tomas J. Ekström, Eva Hellström‐Lindberg, Martin Schalling, Catharina Larsson, Georgy Bakalkin, Sven‐Erik Johansson, Monika Jansson, Stefan Deneberg, Bengt Lindholm and Frank Lyko. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.